Fluvastatin Sodium (Teva Pharmaceuticals USA, Inc.)


Welcome to the PulseAid listing for the Fluvastatin Sodium drug offered from Teva Pharmaceuticals USA, Inc.. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Pharmaceuticals USA, Inc.
NON-PROPRIETARY NAME: Fluvastatin Sodium
SUBSTANCE NAME: FLUVASTATIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-06-02
END MARKETING DATE: 0000-00-00


Fluvastatin Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFluvastatin Sodium from Teva Pharmaceuticals USA, Inc.
LABELER NAME: Teva Pharmaceuticals USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 80(mg/1)
START MARKETING DATE: 2016-06-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0093-7446_a4ec780a-dfd4-4116-a405-2de6e6626cc1
PRODUCT NDC: 0093-7446
APPLICATION NUMBER: ANDA079011

Other FLUVASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementFluvastatin Sodium
Mylan Pharmaceuticals Inc.Fluvastatin Sodium
Novartis Pharmaceuticals CorporationLescol
Physicians Total Care, Inc.LESCOL
Sandoz IncFLUVASTATIN SODIUM
Teva Pharmaceuticals USA, Inc.Fluvastatin